Market Research Assistance

On the Web
Refine Result

By Date

Last Month
Last 3 Months
Last 6 Months
Last Year
Last 2 Years

By Price

< $1000
$1000-$2500
$2501-$4000
$4001-$5500
$5501-$7500
$7501-$9000
>$9000

Infectious Diseases Therapeutics Market Research Reports

Titlepublishedprice

Community Acquired Pneumonia - Pipeline Review, H2 2015

By Global Markets Direct
"...... ive information on the therapeutic development for Community Acquired Pneumonia, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type,......"
22-Jul-2015$2000

Bacterial Vaginosis - Pipeline Review, H2 2015

By Global Markets Direct
"...... apeutic development for Bacterial Vaginosis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and feat......"
22-Jul-2015$2000

Dengue - Pipeline Review, H2 2015

By Global Markets Direct
"...... y drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Dengue and special fea......"
15-Jul-2015$2000

EpiCast Report: Genital Herpes - Epidemiology Forecast to 2023

By GlobalData
"...... o forms: HSV-1 and HSV-2. The majority of genital herpes cases globally are caused by HSV-2, although approximately half of all new cases in developed countries are caused by HSV-1. Most cases of genital herpes are asymptomatic, leading to the diagno......"
10-Jul-2015$3995

Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections - Pipeline Review, H1 2015

By Global Markets Direct
"...... e therapeutic development for Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and mo......"
30-Jun-2015$2000

Streptococcus Pneumoniae Infection - Pipeline Review, H1 2015

By Global Markets Direct
"...... ection, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also......"
30-Jun-2015$2000

Pseudomonas Aeruginosa Infections - Pipeline Review, H1 2015

By Global Markets Direct
"...... ons, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also re......"
30-Jun-2015$2000

Respiratory Syncytial Virus (RSV) Infections - Pipeline Review, H1 2015

By Global Markets Direct
"...... ory Syncytial Virus (RSV) Infections, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured ne......"
30-Jun-2015$2000

Respiratory Syncytial Virus (RSV) Infections Global Clinical Trials Review, H1, 2015

By GlobalData
"...... ory Syncytial Virus (RSV) Infections. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase......"
30-Jun-2015$2500

Investigation Report on China Imipenem and cilastatin sodium Market, 2010-2019

By China Research and Intelligence
"...... ss. Developed by Merck & Sharp Dohme (US) in 1979, imipenem and cilastatin sodium is the most famous one in imipenem cilastatin class. Its sales value around the world was USD 610 million in 2011 and USD 520 million in 2012, down 25.4% ye......"
25-Jun-2015$2000